David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
The GEO Group
GEO
$4.22B
| $1.63M | ﹤0.01% |
97,205
+42,708
| +78% | +$678K |
|
|
KEEL
2977
Keel Infrastructure Corp
KEEL
$2.22B
| $1.63M | ﹤0.01% |
832,730
+483,830
| +139% | +$1.14M |
|
2978
Hawaiian Electric Industries
HE
$1.96B
| $1.63M | ﹤0.01% |
109,856
+81,434
| +287% | +$1.23M |
|
2979
NCR Atleos
NATL
$3.41B
| $1.63M | ﹤0.01% |
37,377
-15,087
| -29% | -$624K |
|
2980
Digimarc Corp
DMRC
$144M
| $1.63M | ﹤0.01% |
331,409
+29,768
| +10% | +$165K |
|
2981
Stoke Therapeutics
STOK
$2.1B
| $1.63M | ﹤0.01% |
49,972
+71
| +0.1% | +$2.33K |
|
2982
PUT
Papa John's
PZZA
$764M
| $1.62M | ﹤0.01% |
+50,000
| New | +$1.74M |
|
2983
Northern Trust
NTRS
$34.1B
| $1.62M | ﹤0.01% |
11,598
-16,844
| -59% | -$2.42M |
|
2984
PUT
Genuine Parts
GPC
$18.9B
| $1.62M | ﹤0.01% |
+15,300
| New | +$1.89M |
|
2985
CALL
SBA Communications
SBAC
$19.6B
| $1.62M | ﹤0.01% |
+9,400
| New | +$1.76M |
|
2986
CALL
SSR Mining
SSRM
$7.87B
| $1.62M | ﹤0.01% |
+55,000
| New | +$1.46M |
|
2987
CALL
Ambarella
AMBA
$3.13B
| $1.62M | ﹤0.01% |
31,400
-4,400
| -12% | -$274K |
|
2988
AtriCure
ATRC
$2.48B
| $1.61M | ﹤0.01% |
+56,589
| New | +$1.93M |
|
|
HSPT
2989
DELISTED
Horizon Space Acquisition II Corp
HSPT
| $1.61M | ﹤0.01% |
250,000
| – | – |
|
2990
CALL
Praxis Precision Medicines
PRAX
$10.4B
| $1.61M | ﹤0.01% |
5,000
| – | – |
|
2991
Jacobs Solutions
J
$17.7B
| $1.61M | ﹤0.01% |
12,640
+5,491
| +77% | +$747K |
|
2992
CALL
Birkenstock
BIRK
$6.01B
| $1.61M | ﹤0.01% |
+44,900
| New | +$1.75M |
|
2993
Silicon Laboratories
SLAB
$7.3B
| $1.61M | ﹤0.01% |
7,721
-18,416
| -70% | -$3.38M |
|
2994
CALL
GSK
GSK
$101B
| $1.61M | ﹤0.01% |
+29,100
| New | +$1.58M |
|
2995
Codexis
CDXS
$177M
| $1.6M | ﹤0.01% |
979,847
+351,556
| +56% | +$501K |
|
2996
Gaotu Techedu
GOTU
$417M
| $1.59M | ﹤0.01% |
813,435
-7,719
| -0.9% | -$16.9K |
|
2997
CALL
Ero Copper
ERO
$4.13B
| $1.59M | ﹤0.01% |
+59,700
| New | +$1.8M |
|
2998
PUT
Kimberly-Clark
KMB
$36.4B
| $1.59M | ﹤0.01% |
16,500
-17,200
| -51% | -$1.76M |
|
2999
Velocity Financial
VEL
$706M
| $1.59M | ﹤0.01% |
87,734
+72,827
| +489% | +$1.38M |
|
|
CHAR
3000
Charlton Aria Acquisition Corp
CHAR
$120M
| $1.59M | ﹤0.01% |
150,000
| – | – |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.